Gregory Lip joined Aalborg University as a Distinguished Professor in 2018 at the Department of Clinical Medicine, Faculty of Medicine, Aalborg University.

GOOGLE SCHOLAR

Citations: ‪434.400+ citations 
H-index: 223

SCOPUS

Citations: 191.000+ citations
H.index: 167

Research

Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia.

Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines.

Merits, awards and positions

• In 2014 ranked by Expertscape as the world's leading expert in the understanding and treatment of Atrial Fibrillation. Atrial Fibrillation: Worldwide - Expertscape.com
• Has served as senior/section editor for major international textbooks and at the senior editorial level for major international journals, including Thrombosis & Haemostasis, Europace, and Circulation
• Has served on the writing committee for various international guidelines, including the American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation
• Hosts and supervises overseas research fellows, incl. China, Japan, Poland, Italy, Spain, etc.
• Acts as evaluator for academic promotion applicants of national/international universities, e.g. Hong Kong, Amsterdam, Athens, and Israel
• 2019 and 2020: Listed in the “Top 1% in Field” for the Global Peer Review Awards from Publons

Research profile in VBN

For full bio on projects, publications, prizes and much more visit Gregory Yoke Hong Lip's research profile at Aalborg University’s Research Portal.